A vaccine is to be trialled on thousands of people to find out if it could protect against norovirus - a stomach bug that ...

Abrysvo can prevent lower respiratory tract disease caused by RSV for people between the ages of 18 and 59 who are at ...

The U.S. Food and Drug Administration on Tuesday approved Pfizer's RSV vaccine for the prevention of lower respiratory tract ...

The Oxford AstraZeneca vaccine is credited with saving millions of lives but it was also responsible, in rare cases, for ...

High-dose flu vaccinations resulted in a 23% reduction in hospitalizations among people aged 65 years or older, according to ...

The modified vaccinia Ankara-Bavarian Nordic mpox vaccine (MVA-BN; Jynneos) generated robust immune responses in adolescents ...

He said: “The UK is leading the way to develop a world-first vaccine for this vomiting bug, starting with this innovative ...

It is hoped a study will show the jab is effective against the highly infectious disease which puts the NHS under "huge ...

The jab uses mRNA technology to tell the immune system to recognise a ‘foreign’ protein on viruses and mount an attack.

Scientists with the Cleveland clinic are testing a vaccine to possibly prevent the most aggressive and deadly type of breast ...

Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved ABRYSVO® (Respiratory ...

A NEW vaccine that could stop people developing the vomiting bug norovirus is being trialled in the UK - in the hope it could ...